1. Home
  2. HASI vs GRFS Comparison

HASI vs GRFS Comparison

Compare HASI & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hannon Armstrong Sustainable Infrastructure Capital Inc.

HASI

Hannon Armstrong Sustainable Infrastructure Capital Inc.

N/A

Current Price

$37.93

Market Cap

5.4B

Sector

Real Estate

ML Signal

N/A

Logo Grifols S.A.

GRFS

Grifols S.A.

N/A

Current Price

$7.83

Market Cap

5.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HASI
GRFS
Founded
1981
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.2B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
HASI
GRFS
Price
$37.93
$7.83
Analyst Decision
Strong Buy
Hold
Analyst Count
8
2
Target Price
$44.38
$10.15
AVG Volume (30 Days)
785.2K
657.5K
Earning Date
05-07-2026
07-28-2022
Dividend Yield
4.20%
1.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$400,502,000.00
N/A
Revenue This Year
$79.17
$4.49
Revenue Next Year
$207.88
$6.42
P/E Ratio
N/A
$18.67
Revenue Growth
4.41
N/A
52 Week Low
$24.40
$6.96
52 Week High
$44.13
$11.14

Technical Indicators

Market Signals
Indicator
HASI
GRFS
Relative Strength Index (RSI) 44.55 60.27
Support Level $36.68 $7.38
Resistance Level $39.75 $8.24
Average True Range (ATR) 0.90 0.16
MACD 0.04 0.07
Stochastic Oscillator 33.33 87.23

Price Performance

Historical Comparison
HASI
GRFS

About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.

HA Sustainable Infrastructure Capital Inc is an investor in sustainable infrastructure assets advancing the energy transition. Its investment is focused on actively partnering with clients to deploy capital in income-generating real assets that are supported by long-term recurring cash flows. This enabled to the generation of attractive risk-adjusted returns and provided stockholders with diversified exposure to the energy transition. The company's single reportable segment generates net investment and equity method investment income through investments in energy transition assets and infrastructure projects, as well as revenue through the gain on sale of assets and recurring asset management fees.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: